Butler D, Messiha F S
Alcohol. 1986 Mar-Apr;3(2):113-29. doi: 10.1016/0741-8329(86)90021-2.
The use of pharmacologic intervention in the management of alcohol withdrawal syndrome is briefly presented. The use of carbamazepine, a tricyclic anticonvulsant with clinical efficacy in depressive illness, in alcohol withdrawal treatment is reviewed. A comparative analysis between carbamazepine and major drugs used in alcohol withdrawal syndrome is made. This includes the evaluation of both clinical advantages and disadvantages in addition to identification of drug adverse reaction and interaction with alcohol. The mechanism of action of carbamazepine is also examined. Carbamazepine appears to possess a useful pharmacotherapeutic potential in the management of acute alcohol withdrawal syndrome, and its use in long-term treatment is suggested.
简要介绍了药物干预在酒精戒断综合征管理中的应用。回顾了卡马西平(一种对抑郁症有临床疗效的三环类抗惊厥药)在酒精戒断治疗中的应用。对卡马西平和用于酒精戒断综合征的主要药物进行了比较分析。这包括评估临床优缺点,以及识别药物不良反应和与酒精的相互作用。还研究了卡马西平的作用机制。卡马西平在急性酒精戒断综合征的管理中似乎具有有用的药物治疗潜力,并建议将其用于长期治疗。